Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company is mainly engaged in selling health supplements and providing original equipment manufacturing (OEM) services. The Company also outsources manufacturing / OEM services.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume

Real-time OTC Markets

More quotes

Income Statement and Estimates

More financial data

Market Closed - OTC Markets Other stock markets 21:00:15 15/05/2026 +04			5-day change	1st Jan Change
0.3800 ^USD	-.--%		+40.58%	+533.33%

05-19	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	13.45M 11.64M 10.87M 9.97M 18.75M 1.28B 19.05M 127M 50.04M 642M 50.52M 49.41M 2.12B	P/E 2024	-7x	P/E 2025	2.54x
Enterprise Value	15.02M 12.99M 12.13M 11.13M 20.93M 1.43B 21.26M 142M 55.85M 716M 56.39M 55.15M 2.37B	EV / Sales 2024	36.6x	EV / Sales 2025	2.03x
Free-Float	26.52%	Yield 2024 *	-	Yield 2025	-

05-19	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-25	Bio Essence Corporation has entered into a Asset Purchase Agreement to acquire MediFlow AI from Zhituo Software Co., Limited for $3.1 million.	CI
03-27	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
11-12	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
28/03/25	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/03/25	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
14/11/24	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
20/08/24	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
21/06/24	Bio Essence Corporation Announces Board Changes	CI

11-12	Bio Essence : Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q)	PU
07/10/24	Bio Essence : Amendment to Quarterly Report Form 10 Q/A	PU
07/10/24	Bio Essence : Non Reliance of Financial Report Form 8 K	PU
30/03/23	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
16/05/22	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ

Bio Essence Corporation Stock

Stocks

BIOE

US09090C1053

Pharmaceuticals

Valuation: Bio Essence Corporation

Chart: Bio Essence Corporation

Latest news : Bio Essence Corporation

Press Releases: Bio Essence Corporation

Quotes and Performance

Course Extremes

Managers and Directors: Bio Essence Corporation

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	+40.58%
Current month	+40.58%
1 month	+40.58%
3 months	-24.00%
6 months	+595.97%
Current year	+533.33%

1 month	0.24	0.38
Current year	0.05	0.52
1 year	0.05	0.52
3 years	0.05	10.81
5 years	0.05	10.81
10 years	0.05	10.81

Manager	Title	Age	Since
Yin Yan CEO	Chief Executive Officer	50	-
Bill Sluss DFI	Director of Finance/CFO	71	07/09/2023
Tuan Tran COO	Chief Operating Officer	52	01/01/2018

Director	Title	Age	Since
Yin Yan CHM	Chairman	50	-
Siyavash Fooladian BRD	Director/Board Member	54	-
Bill Sluss BRD	Director/Board Member	71	18/06/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
28/10/24	Yin Yan	Sell	Chief Executive Officer	323,845	0.8520%
11/07/24	Yin Yan	Sell	Chief Executive Officer	92,190	0.2425%
02/07/24	Yin Yan	Sell	Chief Executive Officer	223,965	0.5892%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIO ESSENCE CORPORATION	-.--%	+40.58%	+300.00%	-25.49%	13.45M
ELI LILLY AND COMPANY	-0.52%	+3.21%	+89.52%	+125.32%	1,057B
JOHNSON & JOHNSON	+0.88%	+1.13%	+49.56%	+49.79%	625B
ABBVIE INC.	+0.89%	-1.95%	+24.23%	+63.19%	435B
ROCHE HOLDING AG	+0.71%	+3.87%	+49.07%	+38.29%	363B
NOVARTIS AG	+0.64%	-0.49%	+33.94%	+38.94%	296B
ASTRAZENECA PLC	+0.39%	-5.83%	+8.92%	+6.39%	249B
AMGEN INC.	+1.51%	+6.69%	+42.58%	+58.47%	222B
NOVO NORDISK A/S	+3.92%	-0.46%	-5.56%	-51.70%	209B
GILEAD SCIENCES, INC.	+1.80%	+2.30%	+11.56%	+66.16%	165B
Average	+1.02%	+0.85%	+60.38%	+36.94%	362.08B
Weighted average by Cap.	+0.66%	+1.33%	+48.72%	+63.85%

	2024	2025
Net sales	324K 280K 262K 240K 451K 30.83M 459K 3.07M 1.2M 15.45M 1.22M 1.19M 51.09M	1.9M 1.64M 1.53M 1.41M 2.64M 181M 2.69M 17.98M 7.06M 90.52M 7.13M 6.97M 299M
Net income	-1.31M -1.13M -1.06M -970K -1.82M -125M -1.85M -12.4M -4.87M -62.43M -4.91M -4.81M -206M	896K 775K 724K 664K 1.25M 85.29M 1.27M 8.49M 3.33M 42.75M 3.37M 3.29M 141M
Net Debt	2.7M 2.34M 2.18M 2M 3.77M 257M 3.83M 25.62M 10.06M 129M 10.15M 9.93M 426M	1.56M 1.35M 1.26M 1.16M 2.18M 149M 2.21M 14.81M 5.81M 74.56M 5.87M 5.74M 246M